Bromberg-White JL - Search Results

1

MEK genomics in development and disease.

Bromberg-White JL, Andersen NJ, Duesbery NS. Bromberg-White JL, et al. Brief Funct Genomics. 2012 Jul;11(4):300-10. doi: 10.1093/bfgp/els022. Epub 2012 Jun 29. Brief Funct Genomics. 2012. PMID: 22753777 Free PMC article. Review.

2

Biological and biochemical characterization of anthrax lethal factor, a proteolytic inhibitor of MEK signaling pathways.

Bromberg-White JL, Duesbery NS. Bromberg-White JL, et al. Methods Enzymol. 2008;438:355-65. doi: 10.1016/S0076-6879(07)38025-7. Methods Enzymol. 2008. PMID: 18413261

3

Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxin.

Bromberg-White J, Lee CS, Duesbery N. Bromberg-White J, et al. Toxins (Basel). 2010 May;2(5):1038-53. doi: 10.3390/toxins2051038. Epub 2010 May 11. Toxins (Basel). 2010. PMID: 22069624 Free PMC article. Review.

4

MKK signaling and vascularization.

Depeille PE, Ding Y, Bromberg-White JL, Duesbery NS. Depeille PE, et al. Among authors: bromberg white jl. Oncogene. 2007 Feb 26;26(9):1290-6. doi: 10.1038/sj.onc.1210198. Oncogene. 2007. PMID: 17322914 Review.

5

Perturbation of mouse retinal vascular morphogenesis by anthrax lethal toxin.

Bromberg-White JL, Boguslawski E, Duesbery NS. Bromberg-White JL, et al. PLoS One. 2009 Sep 14;4(9):e6956. doi: 10.1371/journal.pone.0006956. PLoS One. 2009. PMID: 19750016 Free PMC article.

6

Persistent inhibition of oxygen-induced retinal neovascularization by anthrax lethal toxin.

Bromberg-White JL, Boguslawski E, Hekman D, Kort E, Duesbery NS. Bromberg-White JL, et al. Invest Ophthalmol Vis Sci. 2011 Nov 21;52(12):8979-92. doi: 10.1167/iovs.11-7651. Invest Ophthalmol Vis Sci. 2011. PMID: 21989728

7

Anthrax Toxin Receptor 1 Is Essential for Arteriogenesis in a Mouse Model of Hindlimb Ischemia.

Andersen NJ, Boguslawski EA, Naidu AS, Szot C, Bromberg-White JL, Kits K, Kuk CY, Holton LE, St Croix B, Chambers CM, Duesbery NS. Andersen NJ, et al. Among authors: bromberg white jl. PLoS One. 2016 Jan 19;11(1):e0146586. doi: 10.1371/journal.pone.0146586. eCollection 2016. PLoS One. 2016. PMID: 26785120 Free PMC article.

8

LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin.

Young JJ, Bromberg-White JL, Zylstra C, Church JT, Boguslawski E, Resau JH, Williams BO, Duesbery NS. Young JJ, et al. Among authors: bromberg white jl. PLoS Pathog. 2007 Mar;3(3):e27. doi: 10.1371/journal.ppat.0030027. PLoS Pathog. 2007. PMID: 17335347 Free PMC article.

9

Identification of VEGF-independent cytokines in proliferative diabetic retinopathy vitreous.

Bromberg-White JL, Glazer L, Downer R, Furge K, Boguslawski E, Duesbery NS. Bromberg-White JL, et al. Invest Ophthalmol Vis Sci. 2013 Oct 3;54(10):6472-80. doi: 10.1167/iovs.13-12518. Invest Ophthalmol Vis Sci. 2013. PMID: 24003089

10

Cytotoxicity of the matrix metalloproteinase-activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cells.

Alfano RW, Leppla SH, Liu S, Bugge TH, Herlyn M, Smalley KS, Bromberg-White JL, Duesbery NS, Frankel AE. Alfano RW, et al. Among authors: bromberg white jl. Mol Cancer Ther. 2008 May;7(5):1218-26. doi: 10.1158/1535-7163.MCT-08-0024. Mol Cancer Ther. 2008. PMID: 18483309 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page